Literature DB >> 22253196

Agreement between self-report and prescription data in medical records for pregnant women.

Preeyaporn Sarangarm1, Bonnie Young, William Rayburn, Pallavi Jaiswal, Melanie Dodd, Sharon Phelan, Ludmila Bakhireva.   

Abstract

BACKGROUND Clinical teratology studies often rely on patient reports of medication use in pregnancy with or without other sources of information. Electronic medical records (EMRs), administrative databases, pharmacy dispensing records, drug registries, and patients' self-reports are all widely used sources of information to assess potential teratogenic effect of medications. The objective of this study was to assess comparability of self-reported and prescription medication data in EMRs for the most common therapeutic classes. METHODS The study population included 404 pregnant women prospectively recruited from five prenatal care clinics affiliated with the University of New Mexico. Self-reported information on prescription medications taken since the last menstrual period (LMP) was obtained by semistructured interviews in either English or Spanish. For validation purposes, EMRs were reviewed to abstract information on medications prescribed between the LMP and the date of the interview. Agreement was estimated by calculating a kappa (κ) coefficient, sensitivity, and specificity. RESULTS In this sample of socially-disadvantaged (i.e., 67.9% high school education or less, 48.5% no health insurance), predominantly Latina (80.4%) pregnant women, antibiotics and antidiabetic agents were the most prevalent therapeutic classes. The agreement between the two sources substantially varied by therapeutic class, with the highest level of agreement seen among antidiabetic and thyroid medications (κ ≥0.8) and the lowest among opioid analgesics (κ = 0.35). CONCLUSIONS Results indicate a high concordance between self-report and prescription data for therapeutic classes used chronically, while poor agreement was observed for medications used intermittently, on an 'as needed" basis, or in short courses.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22253196     DOI: 10.1002/bdra.22888

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  15 in total

1.  Clinical correlates of prescription opioid analgesic use in pregnancy.

Authors:  Megan V Smith; Darce Costello; Kimberly A Yonkers
Journal:  Matern Child Health J       Date:  2015-03

2.  Interaction between Maternal Immune Activation and Antibiotic Use during Pregnancy and Child Risk of Autism Spectrum Disorder.

Authors:  Calliope Holingue; Martha Brucato; Christine Ladd-Acosta; Xiumei Hong; Heather Volk; Noel T Mueller; Xiaobin Wang; M Daniele Fallin
Journal:  Autism Res       Date:  2020-10-16       Impact factor: 5.216

3.  Validation of maternal recall of early pregnancy medication exposure using prospective diary data.

Authors:  Alexandra C Sundermann; Katherine E Hartmann; Sarah H Jones; Eric S Torstenson; Digna R Velez Edwards
Journal:  Ann Epidemiol       Date:  2016-12-09       Impact factor: 3.797

4.  Effects of pain and prescription opioid use on outcomes in a collaborative care intervention for anxiety.

Authors:  Peter Roy-Byrne; Mark D Sullivan; Cathy D Sherbourne; Daniela Golinelli; Michelle G Craske; Greer Sullivan; Murray B Stein
Journal:  Clin J Pain       Date:  2013-09       Impact factor: 3.442

5.  Medication use and drug-related problems among women at maternity wards-a cross-sectional study from two Norwegian hospitals.

Authors:  J Smedberg; M Bråthen; M S Waka; A F Jacobsen; G Gjerdalen; H Nordeng
Journal:  Eur J Clin Pharmacol       Date:  2016-03-29       Impact factor: 2.953

6.  Fetal Growth Outcomes in a Cohort of Polydrug- and Opioid-Dependent Patients.

Authors:  Laura Garrison; Lawrence Leeman; Renate D Savich; Hilda Gutierrez; William F Rayburn; Ludmila N Bakhireva
Journal:  J Reprod Med       Date:  2016 Jul-Aug       Impact factor: 0.142

7.  Agreement Between Maternal Report and Medical Records During Pregnancy: Medications for Rheumatoid Arthritis and Asthma.

Authors:  Kristin Palmsten; Avanthi Hulugalle; Gretchen Bandoli; Grace M Kuo; Shayda Ansari; Ronghui Xu; Christina D Chambers
Journal:  Paediatr Perinat Epidemiol       Date:  2017-10-03       Impact factor: 3.980

8.  Discordant reporting of nonmedical opioid use in a nationally representative sample of US high school seniors.

Authors:  Joseph J Palamar; Jenni A Shearston; Charles M Cleland
Journal:  Am J Drug Alcohol Abuse       Date:  2016-06-17       Impact factor: 3.829

9.  Medication use during pregnancy, gestational age and date of delivery: agreement between maternal self-reports and health database information in a cohort.

Authors:  Federica Edith Pisa; Anica Casetta; Elena Clagnan; Elisa Michelesio; Liza Vecchi Brumatti; Fabio Barbone
Journal:  BMC Pregnancy Childbirth       Date:  2015-11-25       Impact factor: 3.007

10.  Hypnotics use in children 0-18 months: moderate agreement between mother-reported survey data and prescription registry data.

Authors:  Ingvild Holdø; Jørgen G Bramness; Marte Handal; Leila Torgersen; Ted Reichborn-Kjennerud; Eivind Ystrøm; Hedvig Nordeng; Svetlana Skurtveit
Journal:  J Pharm Policy Pract       Date:  2017-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.